Home » Newsletters » BioWorld Science

BioWorld Science

May 7, 2008

View Archived Issues

MDV-3100 well tolerated, reduces PSA in castration-resistant prostate cancer patients

In vitro and in vivo activity against hepatocellular cancer seen with CUDC-101

PDL BioPharma reports development of anti-TweakR antibody with antitumor activity

Serenex describes discovery of SNX-5422, an Hsp90 inhibitor in phase I development

F-14512 activity depends on polyamine transport system status of tumors

Positive preclinical data of Palomid-529 in models of ocular disorders

Evotec completes acquisition of Renovis

Corcept reports promising results from human microdosing study of CORT-108297

Epix initiates phase IIb clinical trial of PRX-03140 in combination with Aricept

NanoViricides reports initial results from mouse studies of HivCide-I for HIV/AIDS

Antennapedia Trojan peptide-p21 fusion protein inhibits tumor cell growth

Bayer Schering Pharma to market new low-dose oral contraceptive in Europe

TG-100801's clinical evaluation discontinued due to phase IIa results

Catalyst selects second-generation factor VIIa variant as candidate for hemophilia

DiaMedica enrolls final patient in phase DM-83 clinical trial

FDA accepts for review Cinryze complete response submission

QRxPharma releases successful phase III study results for Q-8003-IR

Cadence completes full enrollment in phase III CLIRS clincial trial of Omigard

FDA Advisory Committee recommends against approval of Fentora expanded label

Genentech initiates phase II clinical trial of GDC-0449 in metastatic colorectal cancer

Novel agents for treating autoimmune diseases disclosed in recent Pharmacopeia patents

Targacept designates neuronal nicotinic receptor drug in smoking cessation program

Recent patents claim novel therapeutic agents for psychosis, depression and anxiety

LLS and MannKind enter agreement to develop targeted tyrosine kinase inhibitor

Glenmark launches topical antifungal cream Onabet in India

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...